metformin has been researched along with u 62840 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Avolio, T; Bachman, TN; Bai, Y; Baust, JJ; Bonetto, A; Considine, RV; Cook, T; Fisher, A; Gladwin, MT; Goncharov, DA; Goncharova, EA; Halliday, G; Hu, J; Huot, JR; Lai, YC; Machado, RF; McTiernan, CF; Mora, AL; Satoh, T; Sebastiani, A; Tan, J; Vanderpool, RR; Wang, L | 1 |
Mao, Y; Wang, D; Wang, T; Xiong, T; Yang, X | 1 |
Komamura, K | 1 |
3 other study(ies) available for metformin and u 62840
Article | Year |
---|---|
Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.
Topics: AMP-Activated Protein Kinases; Animals; Antihypertensive Agents; Diet, High-Fat; Epoprostenol; Heart; Heart Failure; Hyperglycemia; Hypertension, Pulmonary; Hypoglycemic Agents; Insulin Resistance; Male; Metabolic Syndrome; Metformin; Mice; Mice, Inbred C57BL; Obesity; Rats; Receptors, Leptin; Stroke Volume | 2020 |
Letter by Wang et al Regarding Article, "Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction".
Topics: Epoprostenol; Heart Failure; Humans; Hyperglycemia; Hypertension, Pulmonary; Metformin; Stroke Volume | 2020 |
Letter by Komamura Regarding Article, "Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction".
Topics: Epoprostenol; Heart Failure; Humans; Hyperglycemia; Hypertension, Pulmonary; Metformin; Stroke Volume | 2020 |